A model for a smallpox-vaccination policy

New England Journal of Medicine

Volumn 348, Issue 5, 2003, Pages 416-425

  Bozzette, Samuel A ^a   Boer, Rob ^a   Bhatnagar, Vibha ^b   Brower, Jennifer L ^b   Keeler, Emmett B ^a   Morton, Sally C ^a   Stoto, Michael A ^b  

^a RAND CORPORATION   (United States)

^b RAND Health Care ^*

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

ARTICLE; BIOLOGICAL WARFARE; EPIDEMIC; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFECTION RISK; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RISK ASSESSMENT; SMALLPOX; VACCINATION;

BIOTERRORISM; DISEASE OUTBREAKS; HEALTH POLICY; HISTORY, 20TH CENTURY; HUMANS; IMMUNIZATION PROGRAMS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; SMALLPOX; SMALLPOX VACCINE; UNITED STATES;

EID: 0037472883     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsa025075     Document Type: Article

References (36)

1. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. JAMA 1999;281:2127-37.
2. Schmemann S. Israel begins vaccinating health workers for smallpox. New York Times. August 17, 2002:A3.
3. Falkenrath RA, Newman RD, Thayer BA. America's Achilles' heel: nuclear, biological, and chemical terrorism and covert attack. Cambridge, Mass.: MIT Press, 1998:94-5.
4. Occupational Employment Statistics Program. 2000 National industry-specific occupational employment and wage estimates. Standard Industrial Classification code major group 80: health services. Washington, D.C.: Bureau of Labor Statistics, Department of Labor, 2000.
5. Dick G. Smallpox: a reconsideration of public health policies. Prog Med Virol 1966;8:1-29.
6. Mafart B, Le Camus JL, Mirouze F, Matton T. Les dernières epidémies de variole en France. Sem Hop 1999;75:1265-8.
7. Great Britain Ministry of Health. Smallpox, 1961-62: reports on public health and medical subjects. No. 109. London: Her Majesty's Stationery Office, 1963.
8. Cox P. Committee of Inquiry into the Smallpox Outbreak in London in March and April 1973: report presented to Parliament by the Secretary of State for Social Services by command of Her Majesty, June 1974. London: Her Majesty's Stationery Office, 1974.
9. Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London: Her Majesty's Stationery Office, 1980.
10. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. History of international public health. No. 6. Geneva: World Health Organization, 1988.
11. Leroux M. Smallpox epidemic in Vannes, France, from December 1954 to March 1955. Frederick, Md.: Army Biological Labs, 1956.
12. Dixon CW. Smallpox. London: J. & A. Churchill, 1962.
13. Strom J, Gerzen P, Herzenberg H, Jansson U, Ursing J, Werneman H. Smallpox outbreak and vaccination problems in Stockholm, Sweden, 1963. 3. Diagnosis, clinical classification and symptoms, differential diagnosis and therapy. Acta Med Scand Suppl 1966;464:57-65.
14. Gelfand HM, Posch J. The recent outbreak of smallpox in Meschede, West Germany. Am J Epidemiol 1971;93:234-7.
15. Smallpox - Stockholm, Sweden, 1963. MMWR Morb Mortal Wkly Rep 1996;45: 538-45.
16. Wehrle PF. Smallpox eradication: a global appraisal. JAMA 1978;240:1977-9.
17. Sarkar JK, Mitra AC, Mukherjee MK, De SK, Mazumdar DG. Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients. Bull World Health Organ 1973;48:517-22.
18. Sarkar JK, Mitra AC, Mukherjee MK. Duration of virus excretion in the throat of asymptomatic household contacts of smallpox patients. Indian J Med Res 1974;62:1800-3.
19. Bauer DJ. Vaccination of smallpox contacts. Br Med J 1974;1:576.
20. Henderson DA, Moss B. Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia: W.B. Saunders, 1999:74-97.
21. Fenner F. Poxviruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. New York: Churchill Livingstone, 1997:357-73.
22. Tudor V, Strati I. Smallpox, cholera. Tunbridge Wells, United Kingdom: Abacus Press, 1977.
23. Henderson DA. Smallpox: clinical and epidemiologic features. Emerg Infect Dis 1999;5:537-9.
24. Behbehani AM. The smallpox story: in words and pictures. Kansas City: University of Kansas Medical Center, 1988.
25. Lane JM, Millar JD. Routine childhood vaccination against smallpox reconsidered. N Engl J Med 1969;281:1220-4.
26. Goldstein JA, Neff JM, Lane JM, Koplan JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics 1975;55:342-7.
27. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep 2001;50 (RR-10):1-22.
28. Tignor G. Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen. Ann N Y Acad Sci 1992;653:334-43.
29. Sharp JC, Fletcher WB. Experience of anti-vaccinia immunoglobulin in the United Kingdom. Lancet 1973;1:656-9.
30. Facts about small-pox and vaccination, and the lessons of a hundred years of vaccination in Europe, 1796-1896. London: British Medical Association, 1902.
31. Copeman PWM. Eczema vaccinatum. BMJ 1964;2:906-8.
32. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970;122:303-9.
33. Pollock T. Human immunoglobulin in prophylaxis. Br Med Bull 1969;25:202-7.
34. Kempe CH. Studies on smallpox and complications of smallpox vaccination: E. Mead Johnson Award address. Pediatrics 1960;26:176-89.
35. Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A 2002;99:10935-40.
36. Halloran ME, Longini IM Jr, Nizam A, Yang Y. Containing bioterrorist smallpox. Science 2002;298:1428-32.